Comorbidity of parkinsonism and schizophrenia in a patient treated with clozapine
暂无分享,去创建一个
J. Libiger | K. Kupka | L. Hosák | A. Urban
[1] Merja Haaparanta,et al. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia , 2001, Schizophrenia Research.
[2] D. Linszen,et al. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT , 2001, Schizophrenia Research.
[3] J. Krystal,et al. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]β-CIT , 2000, Biological Psychiatry.
[4] C. Trenkwalder,et al. Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy? , 1998, Psychiatry Research: Neuroimaging.
[5] Abraham Weizman,et al. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. , 1997, The Journal of clinical psychiatry.
[6] H. Lublin,et al. Extrapyramidal Symptoms during Long-Term Treatment with Antipsychotics , 1996, Neuropsychopharmacology.